{"id":"incobotulinumtoxina-100-unt-injection-xeomin","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Injection site pain or bruising"},{"rate":"5-15","effect":"Headache"},{"rate":"1-5","effect":"Muscle weakness or paralysis (off-target)"},{"rate":"1-3","effect":"Ptosis (eyelid drooping)"},{"rate":"1-5","effect":"Dry mouth"},{"rate":"5-10","effect":"Neck pain"}]},"_chembl":{"chemblId":"CHEMBL2108035","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IncobotulinumtoxinA is a botulinum toxin serotype A that irreversibly cleaves SNAP-25, a protein essential for acetylcholine vesicle fusion and release. This prevents neuromuscular transmission, resulting in localized muscle weakness or paralysis. The effect is temporary, typically lasting 3-4 months, after which neuromuscular function gradually recovers.","oneSentence":"IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:50.806Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Hemifacial spasm"},{"name":"Glabellar lines (wrinkles)"},{"name":"Spasticity"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Incobot/A"],"phase":"phase_3","status":"active","brandName":"IncobotulinumtoxinA 100 UNT Injection [Xeomin]","genericName":"IncobotulinumtoxinA 100 UNT Injection [Xeomin]","companyName":"University Of Perugia","companyId":"university-of-perugia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Hemifacial spasm.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}